Treatment with recombinant activated factor VII in a patient with hemophilia A and an inhibitor: advantages of administration by continuous infusion over bolus intermittant injections - Scaraggi, FA; De Mitrio, V; Marino, R; Speciale, V; Di Bari, L; Petronelli, M; Schiraldi, O (Blood Coagul Fibrinolysis, 1999)